Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

ARGAN INC Director's Dealing 2019

Apr 26, 2019

31210_dirs_2019-04-26_00f19f77-3128-4ab9-8f78-422fe316f77c.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: ARGAN INC (AGX)
CIK: 0000100591
Period of Report: 2019-04-24

Reporting Person: MITCHELL W G CHAMPION (Director)

Non-Derivative Transactions

Date Security Code Shares Price A/D Holdings After Ownership
2019-04-24 Common Stock M 53333 $25.94 Acquired 53333 Direct
2019-04-25 Common Stock S 7788 $49.73 Disposed 45545 Direct
2019-04-26 Common Stock S 17212 $49.27 Disposed 28333 Direct

Derivative Transactions

Date Security Exercise Price Code Shares A/D Expiration Underlying Ownership
2019-04-24 Stock Option to purchase Common Stock $ M 53333 Disposed Common Stock (53333) Direct

Holdings (Non-Derivative)

Security Shares Ownership
Common Stock 7500 Indirect

Footnotes

F1: On April 24, 2019, the Reporting Person exercised his stock option to purchase (i) 5,000 shares of the Issuer's common stock at a price of $12.43 per share with a Date Exercisable 12/17/2010 and Expiration Date of 12/17/2019; (ii) 5,000 shares of the Issuer's common stock at a price of $17.33 with a Date Exercisable of 12/20/2012 and Expiration Date of 12/20/2021; (iii) 10,000 shares of the Issuer's common stock at a price of $18.87 per share with Date Exercisable of 12/18/2013 and Expiration Date of 12/18/2022; (iv) 10,000 shares of the Issuer's common stock at a price of $26.88 per share with Date Exercisable of 12/17/2014 and Expiration date of 12/17/2023;

F2: (v) 10,000 shares of the Issuer's common stock at a price of $31.82 per share with Date Exercisable of 12/11/2015 and Expiration Date of 12/11/2024; (vi) 10,000 shares of the Issuer's common stock at a price of $30.44 per share with Date Exercisable 1/7/2017 and Expiration Date of 1/7/2026; and (vii) 3,333 shares of the Issuer's common stock at a price of $46.35 per share Date Exercisable of 1/11/2019 and Expiration Date of 1/11/2028. The average exercise price per share of the Issuer's common stock was $25.94.

F3: On April 25, 2019, the Reporting Person sold 7,788 shares of the Issuer's common stock on the open market at an average price of $49.73 per share.

F4: On April 26, 2019, the Reporting Person sold 17,212 shares of the Issuer's common stock on the open market at an average price of $49.27 per share.

F5: As of the date of this filing, the Reporting Person owns options to purchase (i) 10,000 shares of common stock at a price of $71.75 per share with Date Exercisable of 1/5/2018 and Expiration Date of 1/5/2027; (ii) 6,667 shares of common stock at a price of $46.35 per share, subject to a three-year ratably vesting schedule, with Date Exercisable of 1/11/2019 and Expiration Date of 1/11/2028; and (iii) options to acquire shares of common stock at a price of $41.19 per share, subject to a three-year ratably vesting schedule, with initial Date Exercisable beginning on 12/12/2019 and Expiration date of 12/12/2028.